- STAT+: What’s in the last-minute flurry of health care bills?Congress is scrambling to advance a slew of health care bills before an August recess. Price transparency and prior authorization top the list.STAT · 3d ago↗ source
- FDA panel confronting peptide controversyToday's biotech news features the FDA weighing the fate of peptides; approvals for RevMed, GSK; and data on Lilly's "triple-G."STAT · 3d ago↗ source
- Merck CEO cautions Congress on imposing limits on Chinese dealmakingMerck CEO Rob Davis said he has warned Congress and the Trump administration that if they cut off or hamper US-China dealmaking, the US could lose its status as the world's biotech leader. China-…Endpoints